Adalimumab: all 321 studies that test it

Page 4 of 4. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger JointsCompletedNCT00296894Phase 2
• Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early ArthritisStatus unknownNCT00291915Phase 4
• A Study of Adalimumab to Treat Sarcoidosis of the SkinCompletedNCT00274352Phase 2
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00237887Phase 3
• Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT00235885Phase 3
• Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00235859Phase 3
• Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00235820Phase 3
• D2E7-Early ASStatus unknownNCT00235105Phase 2/3
• Quality of Life Study With Adalimumab in Rheumatoid ArthritisCompletedNCT00234936Phase 3
• Efficacy of HUMIRA in Subjects With Active Rheumatoid ArthritisCompletedNCT00234897Phase 4
• Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid ArthritisCompletedNCT00234845Phase 3
• Predictors of the Response to Adalimumab in Rheumatoid ArthritisCompletedNCT00234234Phase 4
• A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid ArthritisCompletedNCT00233571Phase 3
• Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid ArthritisTerminatedNCT00233558Phase 4
• Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisStatus unknownNCT00216177Phase 4
• Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)CompletedNCT00193648Phase 1
• A Pilot Trial of Adalimumab for the Treatment of OsteoarthritisCompletedNCT00185562Phase 2
• Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00105300Phase 3
• Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00077779Phase 3
• A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00055523Phase 2
• Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid ArthritisCompletedNCT00049751Phase 3

← Adalimumab overview